companyprofile
Actions
Almoosa Health Co.
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 141.80
-
Open 142.80
-
High 144.60
-
Low 140.00
-
No. of Trades 6,647
-
Avg. Trade size* 110
-
Volume Traded 734,519
-
Value Traded (SAR) 104,850,655.80
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2023-12-31 | |||
|---|---|---|---|---|
| Total Assets |
2,301,799
|
- | - | - |
| Total Liabilities |
1,645,795
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
656,004
|
- | - | - |
| Total Liabilities and Shareholders Equity |
2,301,799
|
- | - | - |
| Statement of Income | 2023-12-31 | |||
| Total Revenue (Sales/Operating) |
978,975
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
101,776
|
- | - | - |
| Zakat and Income Tax |
-3,630
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
98,146
|
- | - | - |
| Total Comprehensive Income |
3,213
|
- | - | - |
| Profit (Loss) per Share |
2.8
|
- | - | - |
| Cash Flows | 2023-12-31 | |||
| Net Cash From Operating Activities |
40,070
|
- | - | - |
| Net Cash From Investing Activities |
-454,386
|
- | - | - |
| Net Cash From Financing Activities |
414,915
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
15,240
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
15,839
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | SAR | |||
| Last Update Date | 2025-01-09 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-03-31 | ||
|---|---|---|---|---|
| Total Assets |
2,408,912
|
2,340,645
|
||
| Total Liabilities |
1,746,942
|
1,697,827
|
||
| Total Shareholders Equity (After Deducting the Minority Equity) |
661,970
|
642,818
|
||
| Total Liabilities and Shareholders Equity |
2,408,912
|
2,340,645
|
||
| Statement of Income | 2024-09-30 | 2024-03-31 | ||
| Total Revenue (Sales/Operating) |
308,477
|
277,157
|
||
| Net Profit (Loss) before Zakat and Tax |
28,745
|
16,327
|
||
| Zakat and Income Tax |
-818
|
-2,600
|
||
| Net Profit (Loss) after Zakat and Tax |
27,928
|
13,727
|
||
| Total Comprehensive Income |
947
|
- | ||
| Profit (Loss) per Share |
0.82
|
0.39
|
||
| Cash Flows | 2024-09-30 | 2024-03-31 | ||
| Net Cash From Operating Activities |
143,546
|
27,646
|
||
| Net Cash From Investing Activities |
-172,534
|
-54,355
|
||
| Net Cash From Financing Activities |
46,931
|
19,081
|
||
| Cash and Cash Equivalents, Beginning of the Period |
15,839
|
15,839
|
||
| Cash and Cash Equivalents, End of the Period |
33,781
|
8,211
|
||
| All Figures in | Thousands | Thousands | ||
| All Currency In | SAR | SAR | ||
| Last Update Date | 2025-01-09 | 2025-01-09 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The Company primarily operates in the healthcare sector, providing integrated services that encompass primary, acute, and rehabilitative care. It manages facilities in various healthcare areas, including hospitals, medical and dental clinics, pharmaceutical services, telemedicine services, and other health-related services. Additionally, the company''s activities extend throw its sub branches and support activities to include transportation and storage, specifically focusing on warehousing medical and pharmaceutical items. Beyond healthcare, it also engages in the arts, leisure, and entertainment sectors, operating a restaurant and a gym.
Company History
In 1994G, the Company commenced its operations as a branch of Abdulaziz Abdullah Abdulwahab Almoosa Commercial Sole Proprietorship under the name Al Moosa Specialist Hospital (Al Ahsa), which is registered in the Commercial Register of the city of Al Mubarraz under No. 2252022248 dated 06/09/1414H (corresponding to 17/02/1994G). Pursuant to the Company'''' s Articles of Association reviewed by the Ministry of Commerce and registered with the notary public by the Partners under No. 391474381, dated 22/09/1439H (corresponding to 06/06/2018G), the branch of Abdulaziz Abdullah Abdulwahab Almoosa Commercial Sole Proprietorship was transformed into a limited liability company under the name Al Moosa Specialist Hospital with a fully paid share capital of SAR 1,000,000, divided into 100,000 cash shares with a fully paid nominal value of SAR 10 per share. Pursuant to the Partners resolution dated 04/03/1442H (corresponding to 21/10/2020G) and Ministry of Commerce resolution No. 47, dated 04/03/1442H (corresponding to 21/10/2020G), the Company was transformed from a limited liability company into a closed joint stock company under the name Al Moosa Specialist Hospital with a fully paid share capital of SAR 1,000,000, divided into 100,000 ordinary Shares with a fully paid nominal value of SAR 10 per Share. Pursuant to the Extraordinary General Assembly resolution dated 11/06/1445H (corresponding to 24/12/2023G), the Company''''s share capital was increased from SAR 1,000,000 to SAR 350,000,000, divided into 35,000,000 fully paid ordinary Shares with a nominal value of SAR 10 per Share. On 04/08/1445H (corresponding to 14/02/2024G), Abdulaziz Abdullah Almoosa, who owned 28,000,000 Shares of the Company''''s share capital, transferred 1,750,000 of the Company Shares to Abdulaziz bin Abdullah Almoosa Charity Company. On 04/08/1445H (corresponding to 14/02/2024G), the Extraordinary General Assembly approved changing the name of the Company from Al Moosa Specialist Hospital to Almoosa Health Company. On 16/09/1445H (corresponding to 26/03/2024G), (1) Abdulaziz Abdullah Almoosa, (2) Habiba Abdulrahman Almoosa, (3) Mohammad Abdulaziz Almoosa, (4) Malek Abdulaziz Almoosa, (5) Sara Abdulaziz Almoosa, (6) Zainab Abdulaziz Almoosa, (7) Omaima Abdulaziz Almoosa, (8) Yaser Abdulaziz Almoosa, (9) Yousef Abdulaziz Almoosa, (10) Lama Abdulaziz Almoosa, and (11) Ahmed Abdulaziz Almoosa transferred all their Shares in the Company, totaling 33,250,000 Shares to Abdulaziz bin Abdullah Almoosa Investment Company in exchange for granting them Shares therein. On 16/10/1445H (corresponding to 25/04/2024G), the Company'''' s Extraordinary General Assembly approved the Company''''s capital increase from SAR 350,000,000 divided into 35,000,000 fully paid ordinary Shares with a nominal value of SAR 10 per Share to SAR 443,035,800, divided into 44,303,580 ordinary Shares with a nominal value of SAR 10 per Share.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 443,035,800
- Issued Shares 44,303,580
- Paid Capital (SAR) 443,035,800
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2025-01-07
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Investor Relations
Company Address:
3256 Dahran St Alkhars district PO 5098
Contact Details:
Telephone:
Ext. 1115 0135369666
Fax
: 0135304440
Email
: investor.relations@almoosahealth.com.sa
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}